Abstract
Aspergillus is one of the most prevalent airborne fungal pathogens in the developed countries that may cause fatal invasive pulmonary aspergillosis in immunocompromised patients. The epidemiological information on aspergillosis in Poland is scarce. This retrospective, population-based study evaluated the incidence of pulmonary and other forms of aspergillosis, and also gender distribution and territorial differences in the occurrence of aspergillosis in hospitalized patients in Poland during 2009–2016. The incidence of aspergillosis was estimated on the basis of a dataset provided by hospital morbidity study carried out by the National Institute of Public Health. The data consisted of 4206 hospitalization records of 2338 patients, with some patients being hospitalized more than one time due to disease remissions. Significant gender differences were observed (1484 females vs. 2722 males, p < 0.001). No statistical differences were found for the place of residence. The average annual incidence rates for all forms of aspergillosis, invasive pulmonary aspergillosis, and other pulmonary aspergillosis were 13.8 per million (95% CI: 11.3–16.3), 4.0 per million (95% CI: 3.0–5.0), and 4.4 (CI: 3.5–5.2) per million, respectively. Over time, a significant increase in the rate of hospitalization were observed for all forms of aspergillosis (10.7 per million in 2009 vs. 15.7 per million in 2016, p for trend <0.005), invasive pulmonary aspergillosis (2.3 per million in 2009 vs. 5.0 per million in 2016, p for trend <0.001), and other pulmonary aspergillosis (3.6 per million in 2009 vs. 4.9 per million in 2016, P for trend <0.02). During the period analyzed 283 patients (12.0%) died while hospitalized and 224 of them (9.6% of all patients) died during the first-time hospitalization. We conclude that the incidence of aspergillosis is on the rise in hospitalized patients in Poland.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abramson JH (2011) WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol Perspec Innov 8(1):1. https://doi.org/10.1186/1742-5573-8-1
Agarwal R, Denning DW, Chakrabarti A (2014) Estimation of the burden of chronic and allergic pulmonary aspergillosis in India. PLoS One 9:e114745
Al Shair K, Atherton GT, Harris C, Ratcliffe L, Newtop PJ, Denning DW (2013) Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis. Clin Infect Dis 57:828–835
Baddley JW, Stephens JM, Ji X, Gao X, Schlamm HT, Tarallo M (2013) Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes. BMC Infect Dis 13:29. https://doi.org/10.1186/1471-2334-13-29
Blanchard E, Gabriel F, Jeanne-Leroyer C, Servant V, Dumas P-Y (2018) Invasive pulmonary aspergillosis. (Article in French). Rev Mal Respir 35:171–187
Borys M, Piwowarczyk P, Sysiak J, Czuczwar M, Prystupa A (2017) Early diagnosis and treatment of invasive aspergillosis as a main determinant of outcome – review of literature according to the presented case report. Ann Agric Environ Med 24:100–103
Cadranel J, Philippe B, Hennequin C, Bergeron A, Bergot E, Bourdin A, Cottin V, Jeanfaivre T, Godet C, Pineau M, Germaud P (2012) Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial. Eur J Clin Microbiol Infect Dis 31:3231–3239
Central Statistical Office of Poland (2018) http://stat.gov.pl. Accessed on 30 July 2018
Chakrabarti A, Chatterjee SS, Das A, Shivaprakash MR (2011) Invasive aspergillosis in developing countries. Med Mycol 49(Suppl 1):35–47
Chan JF, Lau SK, Wong SC, To KK, So SY, Leung SS, Chan SM, Pang CM, Xiao C, Hung IF, Cheng VC, Yuen KY, Woo PC (2016) A 10-year study reveals clinical and laboratory evidence for the “semi-invasive” properties of chronic pulmonary aspergillosis. Emerg Microbes Infect 5:e37
Chrdle A, Mallátová N, Vašáková M, Haber J, Denning DW (2015) Burden of serious fungal infections in the Czech Republic. Mycoses 58(Suppl 5):6–14
De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821
Dell Inc (2016) Dell Statistica – data analysis software system, version 13. https://software.dell.com. Accessed on 13 Dec 2018
Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, Ullmann AJ, Dimopoulos G, Lange C on behalf of the European Society for Clinical Microbiology and Infectious Diseases and European Respiratory Society (2016) Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J 47:45–68
Gamaletsou MN, Drogari-Apiranthitou M, Denning DW, Sipsas NV (2016) An estimate of the burden of serious fungal diseases in Greece. Eur J Clin Microbiol Infect Dis 35:1115–1120
Gangneux J-P, Bougnoux M-E, Hennequin C, Godet C, Chandenier J, Denning DW, Dupont B (2016) An estimation of burden of serious fungal infections in France. J Mycol Med 26:385–390
Hou X, Zhang H, Kou L, Lv W, Lu J, Li J (2017) Clinical features and diagnosis of chronic pulmonary aspergillosis in Chinese patients. Medicine (Baltimore) 96:e8315
Kim A, Nicolau DP, Kuti JL (2011) Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States. Mycoses 54:e301–e312
Lagrou K, Maertens J, Van Even E, Denning DW (2015) Burden of serious fungal infections in Belgium. Mycoses 58(Suppl 5):1–5
Lortholary O, Gangneux J-P, Sitbon K, Lebeau B, de Monbrison F, Le Strat Y, Coignard B, Dromer F, Bretagne S, for the French Mycosis Study Group (2011) Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007). Clin Microbiol Infect 17:1882–1889
Lowes D, Al-Shair K, Newton PJ, Morris J, Harris C, Rautemaa-Richardson R, Denning DW (2017) Predictors of mortality in chronic pulmonary aspergillosis. Eur Respir J 49(2):pii: 1601062. https://doi.org/10.1183/13993003.01062-2016
Mareș M, Moroti-Constantinescu VR, Denning DW (2018) The burden of fungal diseases in Romania. J Fungi (Basel) 4(1):31. https://doi.org/10.3390/jof4010031
Mortensen KL, Denning DW, Arendrup MC (2015) The burden of fungal disease in Denmark. Mycoses 58(Suppl 5):15–21
Nakamoto K, Takayanagi N, Kanauchi T, Ishiguro T, Yanagisawa T, Sugita Y (2013) Prognostic factors in 194 patients with chronic necrotizing pulmonary aspergillosis. Intern Med 52:727–734
Nordøy I, Hesstvedt L, Torp Andersen C, Mylvaganam H, Kols NI, Falch BM, Tofteland S, Müller F, Denning DW (2018) An estimate of the burden of fungal disease in Norway. J Fungi (Basel) 4(1):pii: E29. https://doi.org/10.3390/jof4010029
Ohba H, Miwa S, Shirai M, Kanai M, Eifuku T, Suda T, Hayakawa H, Chida K (2012) Clinical characteristics and prognosis of chronic pulmonary aspergillosis. Respir Med 106:724–729
Pegorie M, Denning DW, Welfare W (2017) Estimating the burden of invasive and serious fungal disease in the United Kingdom. J Infect 74:60–71
Remiszewski P, Langfort R, Podsiadło B, Kuś J, Płodziszewska M, Radzikowska E, Roszkowska B, Szopiński J, Tomkowski W, Wawrzyńska L, Wiatr E, Wierzbicka M, Załeska J, Załeska M, Zych J, Rowińska-Zakrzewska E (2002) Invasive aspergillosis in autopsy material of patients treated at the Institute of Tuberculosis and Chest Diseases during the years 1993–2000. Pneumonol Alergol Pol 70:251–257. (Article in Polish)
Riera FO, Caeiro JP, Denning DW (2018) Burden of serious fungal infections in Argentina. J Fungi (Basel) 4(2):51. https://doi.org/10.3390/jof4020051
Rodriguez-Tudela JL, Alastruey-Izquierdo A, Gago S, Cuenca-Estrella M, León C, Miro JM, Nuñez Boluda A, Ruiz Camps I, Sole A, Denning DW, University of Manchester in association with the LIFE program (2015) Burden of serious fungal infections in Spain. Clin Microbiol Infect 21:183–189
Ruhnke M, Groll AH, Mayser P, Ullmann AJ, Mendling W, Hof H, Denning DW, University of Manchester in association with the LIFE program (2015) Mycoses 58(Suppl 5):22–28
Sabino R, Verissímo C, Brandão J, Martins C, Alves D, Pais C, Denning DW (2017) Serious fungal infections in Portugal. Eur J Clin Microbiol Infect Dis 36:1345–1352
Steinbach WJ, Marr KA, Anaissie EJ, Azie N, Quan S-P, Meier-Kriesche H-U, Apewokin S, Horn DL (2012) Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry. J Infect 65:453–464
Sulik-Tyszka B, Kacprzyk P, Mądry K, Ziarkiewicz-Wróblewska B, Jędrzejczak W, Wróblewska M (2016) Aspergillosis of the heart and lung and review of published reports on fungal endocarditis. Mycopathologia 181:583–588
Sun KS, Tsai CF, Chen SC, Chen YY, Huang WC (2016) Galactomannan testing and the incidence of invasive pulmonary aspergillosis: a 10-year nationwide population-based study in Taiwan. PLoS One 11:e0149964
Swoboda-Kopeć E, Sikora M, Piskorska K, Gołaś M, Netsvyetayeva I, Przybyłowska D, Mierzwińska-Nastalska E (2017) Diagnosis of invasive pulmonary aspergillosis. Adv Exp Med Biol 944:27–33
Taccone FS, Van den Abeele A-M, Bulpa P, Misset B, Meersseman W, Cardoso T, Paiva JA, Blanco-Navalpotro M, De Laere E, Dimopoulos G, Rello J, Vogelaers D, Blot SI, Study Investigators AICU (2015) Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes. Crit Care 19:7. https://doi.org/10.1186/s13054-014-0722-7
Zieliński M, Mazur-Zielińska H, Ziora D (2016) Aspergilloma in atypical localisation in severe asthma patient – case report. Pneumonol Alergol Pol 84:181–185
Zilberberg MD, Nathanson BH, Harrington R, Spalding JR, Shorr AF (2018) Epidemiology and outcomes of hospitalizations with invasive aspergillosis in the United States, 2009–2013. Clin Infect Dis 67(5):727–735
Conflicts of Interest
Authors declare no conflicts of interest in relation to this article.
Ethical Approval
This article is a retrospective study based on the analysis of hospital discharge files. Therefore, the article does not contain any studies with human participants performed by any of the authors. A local Bioethics Committee of Warsaw Medical University in Poland has approved the study.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Tarka, P., Nitsch-Osuch, A., Gorynski, P., Tyszko, P., Bogdan, M., Kanecki, K. (2019). Epidemiology of Pulmonary Aspergillosis in Hospitalized Patients in Poland During 2009–2016. In: Pokorski, M. (eds) Advances in Pulmonary Medicine: Research and Innovations. Advances in Experimental Medicine and Biology(), vol 1160. Springer, Cham. https://doi.org/10.1007/5584_2019_347
Download citation
DOI: https://doi.org/10.1007/5584_2019_347
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21098-4
Online ISBN: 978-3-030-21099-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)